Cyfra 21-1 and TPA as markers in malignant mesothelioma
Bonfrer, J.M.; Schouwink, J.H.; Korse, C.M.; Baas, P.
Anticancer Research 17(4b): 2971-2973
1997
ISSN/ISBN: 0250-7005 PMID: 9329578 Document Number: 476258
Background: Serum concentrations of CEA and Cyfra were compared in patients with mesothelioma. Materials and Methods: Serum levels of patients were analysed for prognosis of survival and follow up of disease. Results: Cyfra 211 and TPA have significant prognostic value for survival. Conclusion: Assays measuring CK19 fragments seem to be good markers in the management of patients with malignant mesothelioma.